The latest price target for Coya Therapeutics (NASDAQ:COYA) was reported by HC Wainwright & Co. on September 16, 2024. The analyst firm set a price target for $18.00 expecting COYA to rise to within 12 months (a possible 167.86% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Coya Therapeutics (NASDAQ:COYA) was provided by HC Wainwright & Co., and Coya Therapeutics initiated their buy rating.

There is no last upgrade for Coya Therapeutics

There is no last downgrade for Coya Therapeutics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.

While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a initiated with a price target of $0.00 to $18.00. The current price Coya Therapeutics (COYA) is trading at is $6.72, which is within the analyst’s predicted range.